EQEbtesam Qasem

Ebtesam Qasem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ebtesam Qasem has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer

    by Avaniyapuram Kannan Murugan, Ebtesam Qasem, Hindi Al-Hindi, Yufei Shi, Ali S. Alzahrani

    BRAF is the most frequently mutated gene in differentiated thyroid cancer (DTC). Previous studies on DTC have well documented high rates of the BRAF V600E mutation in patients of mixed ages. Previous studies either included a mix of pediatric and adult patients or pediatric patients only. However, the prevalence of hotspot and non-hotspot BRAF mutations and its significance in pure adult DTCs is not yet well determined. In this study we determine the frequency of this classical BRAF mutation and other rare BRAF mutations in pure adult DTCs. A total of 204 adult DTC samples (Age >18 years) were analyzed for mutations in exon 15 of the BRAF gene by performing polymerase chain reaction (PCR) amplification of tumor genomic DNAs and direct sequencing of amplicons using Sanger sequencing. Obtained results were correlated to clinical and pathological characteristics of DTCs. Statistical analyses were performed using SPSS (The Statistical Package for Social Sciences) version 20 software. Overall, BRAF mutations were identified in 48.5 % (99/204) of adult DTCs. Three rare non-hotspot mutations (T599I, T599dup and K601E) were detected in four tumor samples (2 %). One (K601E) of these non-hotspot mutations occurred in conventional papillary thyroid cancer (CPTC) and other three (T599I, T599dup and K601E) were found in follicular variant PTC. We found significant association between BRAF V600E mutation and age (P < 0.0001), extrathyroidal invasion (P = 0.017), lymph node metastasis (P = 0.038) and TNM stage III/IV (P = 0.001). Our study is the first to report BRAF mutations in a pure adult sample of DTCs of Saudi Arabian ethnicity. Our results show a high rate and a strong prognostic role of the classical BRAF V600E mutation and also suggest a common occurrence of non-hot spot mutations in adult DTC from this highly inbred population.


  • HABP2 Gene Mutations Do Not Cause Familial or Sporadic Non-Medullary Thyroid Cancer in a Highly Inbred Middle Eastern Population

    by Ali S. Alzahrani, Avaniyapuram Kannan Murugan, Ebtesam Qasem, Hindi Nassir Al-Hindi

    Context: Familial non-medullary thyroid cancer (NMTC) occurs either as part of known hereditary syndromes or as a non-syndromic isolated hereditary tumor. Although the genes underlying the syndromic type of NMTC have been identified in most syndromes, no clear underlying gene has been identified in the non-syndromic NMTC. Recently, a c.1601G>A, p.G534E mutation in the HABP2 gene was reported to be the underlying genetic defect in a family with 7 members affected by NMTC. The G534E variant has also been reported to occur in about 4.7% of cases of the Thyroid Cancer Genome Atlas (TCGA) database. Objectives: To explore whether the recent finding of G534E genetic variant can be replicated in a large sample of NMTC including 11 members of 4 unrelated families with familial NMTC and 509 cases of sporadic pediatric (63 cases) and adult NMTC (446 cases). Methods: We screened all exons and exon-intron boundaries of HABP2 in 11 members of 4 families with familial non-syndromic NMTC using DNA isolated from peripheral leucocytes, PCR and direct sequencing. We also screened specifically for the G534E variant in 229 of sporadic NMTC using DNA isolated from peripheral leucocytes and an additional 217 cases of NMTC using DNA isolated from formalin fixed paraffin embedded tumor tissues. As a control cohort, we screened 190 healthy individuals without known thyroid disease for the presence of the G534E variant using DNA isolated from peripheral leucocytes. Results: None of the familial NMTC carried HABP2 mutations. Of 509 sporadic NMTC, only one case (0.2%) harbored the G534E variant. Similarly, only one case (0.5%) of the control group harbored the G534E variant. Conclusion: In this study, HABP2 mutations were not found in familial NMTC and the G534E variant is not the underlying genetic defect in a large sample of sporadic NMTC from the Middle East.